Volume 272, Number 14,
Issue of April 4, 1997
pp. 9161-9165
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Cytoplasmic Protein mRNA Interaction Mediates cGMP-modulated
Translational Control of the Asialoglycoprotein Receptor
(Received for publication, December 19, 1996, and in revised form, January 29, 1997)
Richard J.
Stockert
and
Qing
Ren
From the Department of Medicine, Marion Bessin Liver Research
Center, Albert Einstein College of Medicine,
New York, New York 10461
Expression of the
asialoglycoprotein receptor by the human hepatocellular carcinoma cell
line HuH-7 in response to intracellular cGMP concentrations was
previously shown to be regulated at the translational level. In a
cell-free system, initiation of asialoglycoprotein receptor mRNA
translation was dependent on the presence of the 7-methylguanylate cap
site and was independent of 8-bromo-cGMP levels in which the cells were
grown prior to RNA isolation. Stable transfection of COS-7 cells with
deletion constructs of the asialoglycoprotein receptor H2b subunit
localized the cGMP-responsive cis-acting element to the mRNA
5
-untranslated region (UTR). Addition of biotin (an activator of
guanylate cyclase) induced the expression of
-galactosidase present
as a chimeric plasmid containing the H2b 187-nucleotide 5
-UTR. An RNA
gel retardation assay identified a 37-nucleotide cognate sequence
within this 187-nucleotide region. Titration of the 5
-UTR with a
cytosolic fraction isolated from HuH-7 grown in the presence or absence
of 8-bromo-cGMP or biotin provided direct evidence for an RNA-binding
protein responsive to intracellular levels of cGMP. Based on these
findings, it seems reasonable to propose that reduction of
intracellular levels of cGMP by biotin deprivation results in a
negative trans-acting factor associating with the 5
-UTR of
asialoglycoprotein receptor mRNAs, thereby inhibiting
translation.